References
- Ademola J.I., Wester R.C., Maibach H.I. Cutaneous metabolism of theophylline by human skin. J. Invest. Dermatol 1992; 98: 310–314
- Ademola J.I., Wester R.C., Maibach H.I. Metabolism of indolylacetic acid during percutaneous absorption skin. J. Pharm. Sci
- Bell E. U.S. Patent No. 4,485,096, 1984, Tissue-equivalent and method for preparation thereof
- Bell E., Ehrlich H.P., Buttle D.J., Nakatsuji T. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 1981; 211: 1052–1054
- Bell E., Gay R., Swiderek M., Class T., Kemp P., Green G., Haimes H., Bilbo P. Use of fabricated living tissue and organ equivalents as defined higher order systems for the study of pharmacologic responses to test substances. Pharmaceutical Applications of Cell and Tissue Culture, G. Wilson, S. Davis, L. Ilium. Plenum Press, New York 1989; 131–137
- Bell E., Ivarsson B., Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. USA 1979; 76: 1274–1278
- Bell E., Parenteau N., Gay R., Nolte C., Temp P., Bilbo P., Ekstein B., Johnson E. The living skin equivalent: Its manufacture, its organotypic properties and its responses to irritants. Toxicol. In Vitro 1991; 5: 591–596
- Bell E., Rosenberg M., Kemp P., Gay R., Green G., Muthukumarun N., Nolte C. Recipes for reconstituting skin. J. Biomechan. Eng
- Bronaugh R.L. Determination of percutaneous absorption by in vitro techniques. Percutaneous Absorption in Dermatology, R.L. Bronaugh, H.I. Maibach. Marcel Dekker, New York 1985; Vol. 6: 267–279
- Bronaugh R.L., Stewart R.F., Storm J.E. Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. Toxicol. Appl. Pharmacol. 1989; 99: 534–543
- Collier S.W., Sheikh N.M., Sakr A., Stewart R.F., Bronaugh R.L. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol. Appl. Pharmacol. 1989; 99: 520–531
- Skelly J.P., Shah V.P., Maibach H.I., Guy R.H., Wester R.C., Flynn G., Yacobi A. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies: Relevance to bioavailability and bioequivalence. 1987
- Green H., Kehinde O., Thomas J. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc. Natl. Acad. Sci. USA 1979; 76: 5665–5668
- Hefton J.M., Finkelstein J.L., Madden M.R., Shires G.T. Grafting of burn patients with allografts of cultured epidermal cells. Lancet 1983; 2: 428–430
- Thivolet J., Faure M., Demidem A., Mauduit G. Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation 1986; 42: 274–280
- Parenteau N.L., Nolte C.M., Bilbo P., Rosenberg M., Wilkins L.M., Johnson E.W., Watson S., Mason V.S., Bell E. Epidermis generated in vitro, practical considerations and applications. J. Cell. Biochem. 1991; 45: 245–251
- Robson R.A., Matheus A.P., Miners J.U., NcManus M.E., Meyer U.A., Hall P.M., Birkette D.J. Characterisation of theophylline metabolism in human liver microsomes. Br. J. Clin. Pharmacol. 1987; 24: 293
- Moloney S.J., Fromson J.M., Bridges J.W. The metabolism of 7-ethoxycoumarin and 7-hydroxycoumarin by rat and hairless mouse skin strips. Biochem. Pharmacol. 1982; 31: 4005–4009